US 11840692
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted A61KA61K31/7105A61K31/713
Quick answer
US patent 11840692 (Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/7105, A61K31/713, A61P, A61P3/06